First published on 21 Feb 2020
Foreword on diverticular disease guidelines for Gut Diverticular disease is to us gastroenterologists as irritable bowel is to our colorectal colleagues: we see it, but don’t know the best way to treat it. Diverticulosis is an extremely common finding in […]
First published on 04 Oct 2019
Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/ Association of Coloproctologists of Great Britain and Ireland (ACPGBI)/ United Kingdom Cancer Genetics Group (UKCGG) They have been reviewed and endorsed by ACPGBI and UKCGG […]
First published on 06 Apr 2018
The College’s Datasets for Histopathological Reporting on Cancers have been written to help pathologists work towards a consistent approach for the reporting of the more common cancers and to define the range of acceptable practice in handling pathology specimens.
First published on 01 Feb 2017
An estimated 175,000 people have Lynch syndrome in the UK, however 95% of those do not know they have it. NICE recommends that microsatellite instability (MSI) testing or immunohistochemistry (IHC) should be used on all colorectal cancers, when first diagnosed, […]
First published on 23 Jun 2015
Matthew D Rutter, Amit Chattree, Jamie A Barbour, Siwan Thomas-Gibson, Pradeep Bhandari, Brian P Saunders, Andrew M Veitch, John Anderson, Bjorn J Rembacken, Maurice B Loughrey, Rupert Pullan, William V Garrett, Gethin Lewis, Sunil Dolwani These guidelines provide an evidence-based […]
First published on 04 Nov 2011
The number of patients with chronic gastrointestinal (GI) symptoms after cancer therapies which have a moderate or severe impact on quality of life is similar to the number diagnosed with inflammatory bowel disease annually. However, in contrast to patients with […]